Proportion of pairs discordant for rating of treatment outcome
Hours after infusion . | Efficacy of treatment . | Bleeding stopped . | ||
---|---|---|---|---|
N . | % Discordant pairs . | N . | % Discordant pairs . | |
2* | 48 | 43.8 | 47 | 40.4 |
6 | 47 | 31.9 | 46 | 32.6 |
12 | 45 | 31.1 | 45 | 33.3 |
24 | 42 | 19.1 | 42 | 14.3 |
36 | 41 | 9.8 | 41 | 12.2 |
48 | 41 | 17.1 | 41 | 7.3 |
Hours after infusion . | Efficacy of treatment . | Bleeding stopped . | ||
---|---|---|---|---|
N . | % Discordant pairs . | N . | % Discordant pairs . | |
2* | 48 | 43.8 | 47 | 40.4 |
6 | 47 | 31.9 | 46 | 32.6 |
12 | 45 | 31.1 | 45 | 33.3 |
24 | 42 | 19.1 | 42 | 14.3 |
36 | 41 | 9.8 | 41 | 12.2 |
48 | 41 | 17.1 | 41 | 7.3 |
Efficacy is defined as effective or partially effective by patient rating.
Prior to second dose of NovoSeven.